Does SELADELPAR Cause Product dose omission issue? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Product dose omission issue have been filed in association with SELADELPAR. This represents 5.1% of all adverse event reports for SELADELPAR.
5
Reports of Product dose omission issue with SELADELPAR
5.1%
of all SELADELPAR reports
0
Deaths
5
Hospitalizations
How Dangerous Is Product dose omission issue From SELADELPAR?
Of the 5 reports, 5 (100.0%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SELADELPAR. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does SELADELPAR Cause?
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)